Latest Breaking News On - Forsyth douglas - Page 1 : vimarsana.com

Inhibrx, Inc. shareholders will receive per share consideration of $30 per share in cash, a CVR equal to $5, plus 0.25 shares in New Inhibrx, a new publicly traded company that retains all non-101.

United statesKayyem jon faizManhard kimberlyForsyth douglasGotshal mangesInhibrx biosciences incSecurities exchangePrnewswire inhibrx incCenterview partnersExchange commissionCompany onParty transactionsInhibrx incAventis incNew inhibrxInhibrx biosciences